Epithelial cell turnover is increased in the excluded stomach mucosa after roux-en-Y gastric bypass for morbid obesity

Obesity Surgery

Volumn 23, Issue 10, 2013, Pages 1616-1623

  Safatle Ribeiro, Adriana V ^a   Petersen, Pedro A ^a   Pereira Filho, Dilson S ^a   Corbett, Carlos E P ^a   Faintuch, Joel ^a   Ishida, Robson ^a   Sakai, Paulo ^a   Cecconello, Ivan ^a   Ribeiro Jr , Ulysses ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bariatric surgery; Bcl 2; Caspase 3; Double balloon endoscopy; Enteroscopy; Gastrin; Ki 67; Morbid obesity; Roux en Y gastric bypass

Indexed keywords

CASPASE 3; CD3 ANTIGEN; CD8 ANTIGEN; GASTRIN; KI 67 ANTIGEN; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOUBLE BALLOON ENTEROSCOPY; ENDOSCOPIC BIOPSY; EPITHELIUM CELL; FEMALE; GASTRIN CELL; GASTRITIS; GASTROINTESTINAL BIOPSY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; BRAZIL; CASPASE 3; CELL PROLIFERATION; DOUBLE-BALLOON ENTEROSCOPY; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GASTRIC BYPASS; GASTRIC MUCOSA; GASTRIC STUMP; GASTRINS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; OBESITY, MORBID;

EID: 84884672821     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0975-2     Document Type: Article

References (37)

1. Weber M, Clavien PA. Bariatric surgery - a successful way to battle the weight crisis. Br J Surg. 2006;93:259-60.
2. Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956-61.
3. Capella RF, Capella JF, Mandec H, et al. Vertical banded gastroplasty-gastric bypass: preliminary report. Obes Surg. 1991;1(4):389-95.
4. Sakai P, Kuga R, Safatle-Ribeiro AV, et al. Is it feasible to reach the bypassed stomach after Roux-en-Y gastric bypass for morbid obesity? The use of the double-balloon enteroscope. Endoscopy. 2005;37:566-9.
5. Fobi MA, Chicola K, Lee H. Access to the bypassed stomach after gastric bypass. Obes Surg. 1998;8(3):289-95.
6. Goitein D, Gagné DJ, Papasavas PK, et al. Percutaneous computed tomography-guided gastric remnant access after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(6):651-5.
7. Silecchia G, Catalano C, Gentileschi P, et al. Virtual gastroduodenoscopy: a new look at the bypassed stomach and duodenum after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2002;12(1):39-48.
8. Sundbom M, Hedenstrom H, Gustavsson S. Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study. Dig Dis Sci. 2002;47:1891-6.
9. Safatle-Ribeiro AV, Kuga R, Iriya K, et al. What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2007;11(2):133-7.
10. Kuga R, Safatle-Ribeiro AV, Faintuch J, et al. Endoscopic findings in the excluded stomach after Roux-en-Y gastric bypass surgery. Arch Surg. 2007;142(10):942-6.
11. Faintuch J, Ishida RK, Jacabi M, et al. Increased gastric cytokine production after Roux-en-Y gastric bypass for morbid obesity. Arch Surg. 2007;142(10):962-8.
12. Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17(6):752-8. Erratum in: Obes Surg. 2007 Jul;17(7):996.
13. Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report. J Clin Gastroenterol. 1991;13(2):191-4.
14. Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67(8):580-2.
15. Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521-3.
16. Escalona A, Guzman S, Ibanez L, et al. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423-7.
17. Trincado MT, del Olmo JC, Garcia Castano J, et al. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215-7.
18. Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932-4.
19. Harper JL, Beech D, Tichansky DS, et al. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268-71.
20. Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3(6):644-7.
21. Clarke MR, Safatle-Ribeiro AV, Ribeiro U, et al. Bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy. Mod Pathol. 1997;10:1021-7.
22. Safatle-Ribeiro AV, Ribeiro Jr U, Sakai P, et al. Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus. Cancer Detect Prev. 2000;24(1):13-23.
23. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-63.
24. Yang L, Wu DY, Xin Y. Down-regulation of caspase-3 expression in precancerous lesions and its relation to gastric carcinogenesis. Zhonghua Zhong Liu Za Zhi. 2006;28(5):357-60.
25. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc. 2010;110(4):571-84.
26. Dalcanale L, Oliveira CP, Faintuch J, et al. Long-term nutritional outcome after gastric bypass. Obes Surg. 2010;20(2):181-7.
27. Hedberg J, Hedenström H, Nilsson S, et al. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15(10):1375-8.
28. Leme PLS, Malheiros CA, Rodrigues FCM, et al. Gastroduodenal exclusion and truncal vagotomy: weight and seric gastrin alterations. Experimental study on rats. Rev Col Bras Cir. 2003;30(6):416-23.
29. Anderi Jr E, Rossi FM, Souza CK, et al. Estudo da gastrinemia pré e pós-operatória em pacientes submetidos à gastroplastia vertical ncom banda e reconstrução em Y de Roux por obesidade mórbida. Rev Col Bras Cir. 2008;35(5):392-6.
30. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735-40.
31. Shiotani A, Iishi H, Ishiguro S, et al. Epithelial cell turnover in relation to ongoing damage of the gastric mucosa in patients with early gastric cancer: increase of cell proliferation in pre-malignant lesions. J Gastroenterol. 2005;40(4):337-44.
32. Csendes A, Burdiles P, Papapietro K, et al. Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg. 2005;9(1):121-31.
33. Madan AK, Lanier BJ, Tichansky DS, et al. Laparoscopic Roux-en-Y gastric bypass with subtotal gastrectomy. Obes Surg. 2005;15(9):1332-5.
34. Braghetto I, Csendes A, Korn O, et al. Laparoscopic resectional gastric bypass in patients with morbid obesity: experience on 112 consecutive patients. J Gastrointest Surg. 2011;15(1):71-80.
35. Menéndez P, Padilla D, Villarejo P, et al. Does bariatric surgery decrease gastric cancer risk? Hepatogastroenterology. 2012;59(114):409-12.
36. Safatle-Ribeiro AV, Ribeiro Jr U, Reynolds JC. Gastric stump cancer: what is the risk? Dig Dis. 1998;16(3):159-68.
37. Sinning C, Schaefer N, Standop J, et al. Gastric stump carcinoma - epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007;33(2):133-9.